280 related articles for article (PubMed ID: 18852183)
1. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.
Turnbull F; Woodward M; Neal B; Barzi F; Ninomiya T; Chalmers J; Perkovic V; Li N; MacMahon S;
Eur Heart J; 2008 Nov; 29(21):2669-80. PubMed ID: 18852183
[TBL] [Abstract][Full Text] [Related]
2. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
Turnbull F; Neal B; Algert C; Chalmers J; Chapman N; Cutler J; Woodward M; MacMahon S;
Arch Intern Med; 2005 Jun; 165(12):1410-9. PubMed ID: 15983291
[TBL] [Abstract][Full Text] [Related]
3. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
Journath G; Hellénius ML; Petersson U; Theobald H; Nilsson PM;
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):258-62. PubMed ID: 18525379
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure and coronary heart disease: a review of the evidence.
Lawes CM; Bennett DA; Lewington S; Rodgers A
Semin Vasc Med; 2002 Nov; 2(4):355-68. PubMed ID: 16222626
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of blood pressure lowering: evidence-based comparisons between men and women.
Turnbull F; Woodward M; Anna V
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):199-209. PubMed ID: 20136606
[TBL] [Abstract][Full Text] [Related]
8. Treating hypertension in women: open-ended questions and therapeutic options.
Morganti A
J Hypertens Suppl; 2002 May; 20(2):S44-6. PubMed ID: 12183851
[TBL] [Abstract][Full Text] [Related]
9. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
Turnbull F;
Lancet; 2003 Nov; 362(9395):1527-35. PubMed ID: 14615107
[TBL] [Abstract][Full Text] [Related]
10. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials.
Czernichow S; Zanchetti A; Turnbull F; Barzi F; Ninomiya T; Kengne AP; Lambers Heerspink HJ; Perkovic V; Huxley R; Arima H; Patel A; Chalmers J; Woodward M; MacMahon S; Neal B;
J Hypertens; 2011 Jan; 29(1):4-16. PubMed ID: 20881867
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
Sever PS; Poulter NR; Dahlof B; Wedel H;
J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
[TBL] [Abstract][Full Text] [Related]
12. [Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials].
Schillaci G; Vaudo G
Ital Heart J Suppl; 2001 Jul; 2(7):799-802. PubMed ID: 11508301
[No Abstract] [Full Text] [Related]
13. Cardiovascular outcomes in the comparative hypertension drug trials: more consensus than controversy.
Ong HT
Singapore Med J; 2008 Aug; 49(8):599-605; quiz 606. PubMed ID: 18756340
[TBL] [Abstract][Full Text] [Related]
14. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
Du X; Ninomiya T; de Galan B; Abadir E; Chalmers J; Pillai A; Woodward M; Cooper M; Harrap S; Hamet P; Poulter N; Lip GY; Patel A;
Eur Heart J; 2009 May; 30(9):1128-35. PubMed ID: 19282274
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
Brugts JJ; Ferrari R; Simoons ML
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.
Ding EL; Powe NR; Manson JE; Sherber NS; Braunstein JB
Arch Intern Med; 2007 May; 167(9):905-12. PubMed ID: 17502531
[TBL] [Abstract][Full Text] [Related]
17. Gender and hypertension management: a sub-analysis of the I-inSYST survey.
Van der Niepen P; Verbeelen D
Blood Press; 2011 Apr; 20(2):69-76. PubMed ID: 21105758
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
[TBL] [Abstract][Full Text] [Related]
19. [Women and hypertension].
Mitchell A; Philipp T
Herz; 2005 Aug; 30(5):401-4. PubMed ID: 16132242
[TBL] [Abstract][Full Text] [Related]
20. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
